Dual energy CT: a possible new method to assess regression of rectal cancers after neoadjuvant treatment

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

90 Downloads (Pure)

Resumé

BACKGROUND AND OBJECTIVES: The measurement of tumor regression after neoadjuvant oncological treatment has gained increasing interest because it has a prognostic value and because it may influence the method of treatment in rectal cancer. The assessment of tumor regression remains difficult and inaccurate with existing methods. Dual Energy Computed Tomography (DECT) enables qualitative tissue differentiation by simultaneous scanning with different levels of energy. We aimed to assess the feasibility of DECT in quantifying tumor response to neoadjuvant therapy in loco-advanced rectal cancer.

METHODS: We enrolled 11 patients with histological and MRI verified loco-advanced rectal adenocarcinoma and followed up on them prospectively. All patients had one DECT scanning before neoadjuvant treatment and one 12 weeks after using the spectral imaging scan mode. DECT analyzing tools were used to determine the average quantitative parameters; effective-Z, water- and iodine-concentration, Dual Energy Index (DEI), and Dual Energy Ratio (DER). These parameters were compared to the regression in the resection specimen as measured by the pathologist.

RESULTS: Changes in the quantitative parameters differed significantly after treatment in comparison with pre-treatment, and the results were different in patients with different CRT response rates.

CONCLUSION: DECT might be helpful in the assessment of rectal cancer regression grade after neoadjuvant treatment.

OriginalsprogEngelsk
TidsskriftJournal of Surgical Oncology
Vol/bind116
Udgave nummer8
Sider (fra-til)984–988
ISSN0022-4790
DOI
StatusUdgivet - 2017

Fingeraftryk

Neoadjuvant Therapy
Rectal Neoplasms
Neoplasms
Iodine

Citer dette

@article{df69f244e9334b8d9dd4be34d44ea7e9,
title = "Dual energy CT: a possible new method to assess regression of rectal cancers after neoadjuvant treatment",
abstract = "BACKGROUND AND OBJECTIVES: The measurement of tumor regression after neoadjuvant oncological treatment has gained increasing interest because it has a prognostic value and because it may influence the method of treatment in rectal cancer. The assessment of tumor regression remains difficult and inaccurate with existing methods. Dual Energy Computed Tomography (DECT) enables qualitative tissue differentiation by simultaneous scanning with different levels of energy. We aimed to assess the feasibility of DECT in quantifying tumor response to neoadjuvant therapy in loco-advanced rectal cancer.METHODS: We enrolled 11 patients with histological and MRI verified loco-advanced rectal adenocarcinoma and followed up on them prospectively. All patients had one DECT scanning before neoadjuvant treatment and one 12 weeks after using the spectral imaging scan mode. DECT analyzing tools were used to determine the average quantitative parameters; effective-Z, water- and iodine-concentration, Dual Energy Index (DEI), and Dual Energy Ratio (DER). These parameters were compared to the regression in the resection specimen as measured by the pathologist.RESULTS: Changes in the quantitative parameters differed significantly after treatment in comparison with pre-treatment, and the results were different in patients with different CRT response rates.CONCLUSION: DECT might be helpful in the assessment of rectal cancer regression grade after neoadjuvant treatment.",
keywords = "Journal Article",
author = "Issam Al-Najami and Drue, {Henrik Christian} and Robert Steele and Gunnar Baatrup",
note = "{\circledC} 2017 Wiley Periodicals, Inc.",
year = "2017",
doi = "10.1002/jso.24761",
language = "English",
volume = "116",
pages = "984–988",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "JohnWiley & Sons, Inc.",
number = "8",

}

Dual energy CT : a possible new method to assess regression of rectal cancers after neoadjuvant treatment. / Al-Najami, Issam; Drue, Henrik Christian; Steele, Robert; Baatrup, Gunnar.

I: Journal of Surgical Oncology, Bind 116, Nr. 8, 2017, s. 984–988.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Dual energy CT

T2 - a possible new method to assess regression of rectal cancers after neoadjuvant treatment

AU - Al-Najami, Issam

AU - Drue, Henrik Christian

AU - Steele, Robert

AU - Baatrup, Gunnar

N1 - © 2017 Wiley Periodicals, Inc.

PY - 2017

Y1 - 2017

N2 - BACKGROUND AND OBJECTIVES: The measurement of tumor regression after neoadjuvant oncological treatment has gained increasing interest because it has a prognostic value and because it may influence the method of treatment in rectal cancer. The assessment of tumor regression remains difficult and inaccurate with existing methods. Dual Energy Computed Tomography (DECT) enables qualitative tissue differentiation by simultaneous scanning with different levels of energy. We aimed to assess the feasibility of DECT in quantifying tumor response to neoadjuvant therapy in loco-advanced rectal cancer.METHODS: We enrolled 11 patients with histological and MRI verified loco-advanced rectal adenocarcinoma and followed up on them prospectively. All patients had one DECT scanning before neoadjuvant treatment and one 12 weeks after using the spectral imaging scan mode. DECT analyzing tools were used to determine the average quantitative parameters; effective-Z, water- and iodine-concentration, Dual Energy Index (DEI), and Dual Energy Ratio (DER). These parameters were compared to the regression in the resection specimen as measured by the pathologist.RESULTS: Changes in the quantitative parameters differed significantly after treatment in comparison with pre-treatment, and the results were different in patients with different CRT response rates.CONCLUSION: DECT might be helpful in the assessment of rectal cancer regression grade after neoadjuvant treatment.

AB - BACKGROUND AND OBJECTIVES: The measurement of tumor regression after neoadjuvant oncological treatment has gained increasing interest because it has a prognostic value and because it may influence the method of treatment in rectal cancer. The assessment of tumor regression remains difficult and inaccurate with existing methods. Dual Energy Computed Tomography (DECT) enables qualitative tissue differentiation by simultaneous scanning with different levels of energy. We aimed to assess the feasibility of DECT in quantifying tumor response to neoadjuvant therapy in loco-advanced rectal cancer.METHODS: We enrolled 11 patients with histological and MRI verified loco-advanced rectal adenocarcinoma and followed up on them prospectively. All patients had one DECT scanning before neoadjuvant treatment and one 12 weeks after using the spectral imaging scan mode. DECT analyzing tools were used to determine the average quantitative parameters; effective-Z, water- and iodine-concentration, Dual Energy Index (DEI), and Dual Energy Ratio (DER). These parameters were compared to the regression in the resection specimen as measured by the pathologist.RESULTS: Changes in the quantitative parameters differed significantly after treatment in comparison with pre-treatment, and the results were different in patients with different CRT response rates.CONCLUSION: DECT might be helpful in the assessment of rectal cancer regression grade after neoadjuvant treatment.

KW - Journal Article

U2 - 10.1002/jso.24761

DO - 10.1002/jso.24761

M3 - Journal article

C2 - 28703886

VL - 116

SP - 984

EP - 988

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 8

ER -